image description

Category: Press Releases

To Increase Diversity in Lupus Clinical Research, Project CHANGE Launches Pilot Programs in Atlanta, Nashville, and Philadelphia

NEW YORK, NY, June 29, 2023 — The clinical research affiliate of the Lupus Research Alliance, Lupus Therapeutics, launched three pilot research initiatives for Project CHANGE, a community-driven approach to address systemic challenges contributing to the underrepresentation of people of color, particularly Black people, in lupus clinical trials. Emory University in Atlanta, Vanderbilt University in Nashville, […] Read More

Lupus Therapeutics Partners to Evaluate Potential Treatment for SLE and Lupus Nephritis Through North American Trial Network

NEW YORK, NY, June 2, 2023 — Lupus Research Alliance clinical research affiliate Lupus Therapeutics will collaborate with Novartis Pharmaceuticals Corporation to conduct  three Phase 3 clinical trials testing an investigational therapeutic ianalumab for systemic lupus erythematosus and lupus nephritis through the Lupus Clinical Investigators Network (LuCIN) at top academic centers throughout North America. Read More

Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus

NEW YORK, NY. May 23, 2023 – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus. As the largest study of its kind in lupus, the Lupus Landmark Studywill follow 3,500 adults […] Read More

Lupus Research Alliance Announces Four New Recipients of the Lupus Mechanisms and Targets Award

Winning projects will explore new potential treatment approaches to prevent lupus from developing or prevent or slow disease progression. NEW YORK, NY, April 20, 2023. The Lupus Research Alliance (LRA) today announced the newest Lupus Mechanisms and Targets Award grant recipients. The winning four projects collectively test potential treatment approaches to prevent lupus from developing […] Read More

Lupus Research Alliance Unites the U.S. Food & Drug Administration (FDA) & Lupus Community to Launch Novel Public-Private Partnership

Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs  WASHINGTON, DC, March 29, 2023 – The Lupus Research Alliance (LRA) today announced the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership bringing people with lupus together in collaboration with the U.S. Food and Drug Administration (FDA), […] Read More

Lupus Research Alliance Appoints New Executive Vice President of Clinical Research Affiliate Lupus Therapeutics

NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) announced the appointment of Stacie J. Bell, PhD as Executive Vice President to lead the organization’s clinical research affiliate Lupus Therapeutics (LT). Dr. Bell comes to Lupus Therapeutics with 25+ years of experience in discovery research, clinical development, and patient engagement in the biopharmaceutical […] Read More

Data at ACR 2022 Shows Lupus Research Alliance Peer Education Program Increases Intentions to Join Clinical Trials Among Diverse Patient Population

NEW YORK, NY–November 8, 2022 — The Lupus Research Alliance and clinical researchaffiliate Lupus Therapeutics will present data at ACR Convergence 2022 showing that the pilot peer education program Patient Advocates for Lupus Studies (PALS), increased knowledge, perception, and intentions among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials. These study results […] Read More